Enavate Sciences GP, LLC

Insider Reports History

Location
New York, NY
Signature
Enavate Sciences GP, LLC, By: /s/ James P. Boylan, Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Enavate Sciences GP, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zenas BioPharma, Inc. 10%+ Owner Common Stock 3,761,359 $63,943,103 $17.00 16 Sep 2024 By Zebra Aggregator, LP
Camp4 Therapeutics Corp 10%+ Owner Common Stock 3,785,802 15 Oct 2024 By Everest Aggregator, LP
Camp4 Therapeutics Corp 10%+ Owner Series B Preferred Stock 0 15 Oct 2024 By Everest Aggregator, LP
Zenas BioPharma, Inc. 10%+ Owner Series B Preferred Stock 0 16 Sep 2024 By Zebra Aggregator, LP
Zenas BioPharma, Inc. 10%+ Owner Series C Preferred Stock 0 16 Sep 2024 By Zebra Aggregator, LP

Insider Reports Filed by Enavate Sciences GP, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CAMP Camp4 Therapeutics Corp 15 Oct 2024 3 +$14,999,996 4 10%+ Owner 17 Oct 2024, 16:15
CAMP Camp4 Therapeutics Corp 10 Oct 2024 0 $0 3 10%+ Owner 10 Oct 2024, 21:22
ZBIO Zenas BioPharma, Inc. 16 Sep 2024 4 +$15,000,001 4 10%+ Owner 18 Sep 2024, 16:15
ZBIO Zenas BioPharma, Inc. 12 Sep 2024 0 $0 3 10%+ Owner 12 Sep 2024, 21:38